Dispatch of Annual General Meeting Documents

Argent Biopharma Limited

25 October 2024

 

25 October 2024

Argent BioPharma Ltd.

(Argent BioPharma or the Company)

Dispatch of Annual General Meeting Documents

Argent BioPharma, an innovative multidisciplinary drug discovery company within the biopharmaceutical sector, would like to advise that it has dispatched the following documentation related to its Annual General Meeting of shareholders to be held at 4:00pm (AWST) on Thursday, 28 November 2024 at Suite 1, 295 Rokeby Road, Subiaco Western Australia 6008, to eligible shareholders.

A copy of which can be found at the following URL:

https://www.investi.com.au/api/announcements/rgt/107493c2-004.pdf

-Ends-

Authorised for release by the board of directors, for further information please contact:

Argent BioPharma Roby Zomer CEO & Managing Director [phone] [e-mail]	Argent BioPharma Rowan Harland Company Secretary [phone] [e-mail]

About Argent BioPharma

Argent BioPharma Limited (the Company) (ASX: RGT; LSE: RGT; OTCQB: RGTLF) an innovative multidisciplinary drug development Company within the biopharmaceutical sector.  The Company focuses on multidisciplinary methods with Nanotechnology, developing multi-target therapies for comprehensive disease management, especially concerning the Central nervous system (CNS) and Immunology treatments.

Follow us through our social media channels:

LinkedIn: Argent BioPharma

Twitter: @ArgentBioPharma

Facebook: Argent BioPharma

 

END